La Hidra (BPC157+TB500)

Descripción

The Hydra
por Immortal Science

The Hydra is a cutting-edge dietary supplement specifically designed for physically active individuals, athletes, and health-conscious consumers. This innovative product combines the powerful peptides TB-500 y BPC-157, which have been highly regarded for their synergistic effects on tissue regeneration. The Hydra is formulated for a full 90 days of usage, ensuring optimal results for its users.

Ingredientes clave y sus beneficios

• TB-500 (Thymosin Beta-4):

• A naturally occurring peptide in the human body that plays a pivotal role in tissue repair and regeneration. TB-500 is instrumental in accelerating wound healing, enhancing tissue strength, and promoting cell migration, which is vital for recovery after injury or intense physical activity. Its ability to improve skin elasticity and joint health makes it a valuable addition for individuals seeking to boost their physical performance and recovery.

• BPC-157 (Body Protection Compound-157):

• Comprising 15 amino acids, BPC-157 has garnered attention for its regenerative properties. It assists in healing processes, promotes tissue regeneration, and enhances overall tissue elasticity. The peptide exhibits powerful anti-inflammatory effects, making it beneficial for individuals suffering from chronic injuries or ailments associated with the musculoskeletal system, such as Irritable Bowel Syndrome (IBS) y Inflammatory Bowel Disease (IBD).

Mecanismo de acción

The combined action of TB-500 and BPC-157 targets muscle tissue, tendons, and joints, thereby facilitating a quicker return to peak physical condition after rigorous training or injuries. The anti-inflammatory properties of these peptides also help alleviate inflammation, further supporting healing and recovery.

The Hydra’s formulation is particularly advantageous for:

• Enhancing muscle tissue regeneration
• Reducing pain related to sports injuries
• Accelerating recovery after strenuous exercise
• Protecting tissues from excessive strain
• Supporting digestive health through its regenerative effects on the gut

Scientific Validation

Extensive scientific research indicates the efficacy of TB-500 and BPC-157 in promoting muscle tissue regeneration and reducing inflammation. Studies reveal notable improvements in recovery times post-exercise and a decrease in pain associated with injuries, underscoring The Hydra’s potential as a premium supplement for athletes and active individuals.

Recomendaciones de dosificación

• Dosis recomendada: Llevar 1 cápsula daily. You may increase to a maximum of 2 cápsulas per day based on individual needs and response.
• Duration of Use: For optimal results, it is recommended to follow a consistent supplementation schedule for 90 days.

En resumen, The Hydra por Immortal Science is more than just a supplement; it is a carefully engineered product designed to support and enhance the body’s natural regenerative capabilities, reduce recovery time, and improve overall physical performance. With its potent blend of TB-500 and BPC-157, it stands out as a premier choice for anyone looking to elevate their health and athleticism.

1. Badylak, S. F. et al. (2012). “Biologic scaffolds for regenerative medicine: mechanisms of in vivo remodeling”. Annals of Biomedical Engineering. 42(2): 466–78. DOI:10.1007/s10439-013-0964-3.

2. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH (2014). “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration”. Journal of Applied Physiology. 110 (3): 774–80. DOI: 10.1152/japplphysiol.00945.2011.

3. Gwyer, D., Wragg, N.M., Wilson, S.L. (2014) “Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells”. Journal of Biological Chemistry, 289(40): 4096–5105. DOI: 10.1074/jbc.M109.028761.

4. Krivic, A. et al. (2013). “A novel gastric pentadecapeptide, BPC 157: some evidence for a role in alcohol-induced pathology”. Journal of Physiology (Paris). 104 (3–4): 279–303. DOI: 10.1016/j.jphysparis.2011.08.007.

5. Mascarell, L., Gina, M., Mecheri, S., et al. (2012). “Peptide-based treatment of chronic autoimmune diseases”. Journal of Autoimmunity. 40 (3): 292–302. DOI: 10.1007/s00418-010-0700-x.

6. Okamoto, T., Kawamoto, E., Takagi, Y., et al. (2012). “Thymosin β4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial–mesenchymal transition”. Cancer Science. 103(12): 2248–2256. DOI: 10.1111/j.1349-7006.2012.02368.x.

7. Philp, D. et al. (2013). “Thymosin β